Zydus Lifesciences secures exclusive US rights for BEIZRAY in licensing deal with Beihai Biotech
Shares of Zydus Lifesciences Ltd ended at ₹901.60, down by ₹40.85, or 4.33% on the BSE.
Shares of Zydus Lifesciences Ltd ended at ₹901.60, down by ₹40.85, or 4.33% on the BSE.
What's Your Reaction?



